F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week
Regulators are set to clear extra doses of Pfizer-BioNTech’s vaccine as soon as Thursday, after states began expanding eligibility on their own.
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.
U.S. Plans to Buy Enough Pfizer Covid Treatment for 10 Million People
Pfizer on Tuesday asked the Food and Drug Administration to authorize its pill for unvaccinated people.
Pfizer Asks F.D.A. to Authorize Covid Pill For Unvaccinated People
The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid, and works differently from the first.
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard by the pandemic.
AstraZeneca Says it Will Start Profiting From its Vaccine
Countries have been paying about $3 to $4 per shot for AstraZeneca’s vaccine under the company’s not-for-profit pricing model.
Johnson & Johnson Will Break Itself Up Into Two Companies
The 135-year-old company announced plans to divide itself into a consumer products business and a medical company.
Biden to Choose Robert Califf to Lead F.D.A., Despite Drug Industry Ties
Dr. Robert M. Califf, an academic and clinical trial researcher who ran the agency in 2016, has also consulted for pharmaceutical companies.
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distribution
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distribution
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.